| Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events A Goyal, DB Reeves, EF Cardozo-Ojeda, JT Schiffer, BT Mayer Elife 10, e63537, 2021 | 180* | 2021 |
| The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality JA Hill, BT Mayer, H Xie, WM Leisenring, ML Huang, T Stevens-Ayers, ... Blood, The Journal of the American Society of Hematology 129 (16), 2316-2325, 2017 | 137 | 2017 |
| Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis BT Mayer, S Srinivasan, TL Fiedler, JM Marrazzo, DN Fredricks, ... The Journal of infectious diseases 212 (5), 793-802, 2015 | 132 | 2015 |
| A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver LT Wang, LS Pereira, Y Flores-Garcia, J O’Connor, BJ Flynn, A Schön, ... Immunity 53 (4), 733-744. e8, 2020 | 103 | 2020 |
| Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding JT Schiffer, BT Mayer, Y Fong, DA Swan, A Wald Journal of The Royal Society Interface 11 (95), 20140160, 2014 | 87 | 2014 |
| Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: a randomized, phase 1 study YZ Cohen, AL Butler, K Millard, M Witmer-Pack, R Levin, C Unson-O’Brien, ... PLoS One 14 (8), e0219142, 2019 | 65 | 2019 |
| Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell transplantation JA Hill, BT Mayer, H Xie, WM Leisenring, ML Huang, T Stevens-Ayers, ... Clinical Infectious Diseases 66 (3), 368-375, 2018 | 61 | 2018 |
| Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells BT Mayer, EM Krantz, D Swan, J Ferrenberg, K Simmons, S Selke, ... Journal of virology 91 (12), 10.1128/jvi. 00380-17, 2017 | 61 | 2017 |
| Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial B Julg, KE Stephenson, K Wagh, SC Tan, R Zash, S Walsh, J Ansel, ... Nature medicine 28 (6), 1288-1296, 2022 | 55 | 2022 |
| Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition PB Gilbert, Y Huang, AC deCamp, S Karuna, Y Zhang, CA Magaret, ... Nature Medicine 28 (9), 1924-1932, 2022 | 46 | 2022 |
| Sm‐p80‐based schistosomiasis vaccine: double‐blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission‐blocking efficacy W Zhang, AJ Molehin, JU Rojo, J Sudduth, PK Ganapathy, E Kim, ... Annals of the New York Academy of Sciences 1425 (1), 38-51, 2018 | 46 | 2018 |
| Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial KE Stephenson, B Julg, CS Tan, R Zash, SR Walsh, CP Rolle, ... Nature medicine 27 (10), 1718-1724, 2021 | 45 | 2021 |
| Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir P Roychoudhury, H De Silva Feelixge, D Reeves, BT Mayer, D Stone, ... BMC biology 16, 1-13, 2018 | 38 | 2018 |
| Nonprimary maternal cytomegalovirus infection after viral shedding in infants I Boucoiran, BT Mayer, EM Krantz, A Marchant, S Pati, S Boppana, A Wald, ... The Pediatric infectious disease journal 37 (7), 627-631, 2018 | 36* | 2018 |
| Dynamics of persistent oral cytomegalovirus shedding during primary infection in Ugandan infants BT Mayer, L Matrajt, C Casper, EM Krantz, L Corey, A Wald, S Gantt, ... The Journal of infectious diseases 214 (11), 1735-1743, 2016 | 34 | 2016 |
| Successes and shortcomings of polio eradication: a transmission modeling analysis BT Mayer, JNS Eisenberg, CJ Henry, MGM Gomes, EL Ionides, ... American journal of epidemiology 177 (11), 1236-1245, 2013 | 33 | 2013 |
| Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation A Goyal, DB Reeves, N Thakkar, M Famulare, EF Cardozo-Ojeda, ... Scientific Reports 11 (1), 11838, 2021 | 25 | 2021 |
| Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials DB Reeves, Y Huang, ER Duke, BT Mayer, EF Cardozo-Ojeda, ... PLoS computational biology 16 (2), e1007626, 2020 | 23 | 2020 |
| Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children L Matrajt, S Gantt, BT Mayer, EM Krantz, J Orem, A Wald, L Corey, ... Scientific reports 7 (1), 13105, 2017 | 22 | 2017 |
| A dynamic dose–response model to account for exposure patterns in risk assessment: a case study in inhalation anthrax BT Mayer, JS Koopman, EL Ionides, JM Pujol, JNS Eisenberg Journal of The Royal Society Interface 8 (57), 506-517, 2011 | 22 | 2011 |
